Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sudarshan Pharma Industries's
Operating Income
for the
three
months ended in Jun. 2026 was ₹145 Mil. Sudarshan Pharma Industries's Interest Expense for the
three
months ended in Jun. 2026 was ₹0 Mil.
Sudarshan Pharma Industries's interest coverage for the quarter that ended in Jun. 2026 was 1.77.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Sudarshan Pharma Industries Ltd interest coverage is 1.86, which is low.
The historical rank and industry rank for Sudarshan Pharma Industries's Interest Coverage or its related term are showing as below:
BOM:543828'
s Interest Coverage Range Over the Past 10 Years
Min: 1.63 Med: 2.32 Max: 3.68
Current: 1.86
BOM:543828's Interest Coverage is ranked worse than 89.04% of 1277
companies
in the Chemicals industry
Industry Median: 11.53
vs BOM:543828: 1.86
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sudarshan Pharma Industries Interest Coverage Related Terms
Sudarshan Pharma Industries Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Chemicals subindustry, Sudarshan Pharma Industries's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudarshan Pharma Industries Interest Coverage vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sudarshan Pharma Industries's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sudarshan Pharma Industries's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sudarshan Pharma Industries (BOM:543828) has a Interest Coverage of 1.77 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sudarshan Pharma Industries and its competitors. This is 24% below median its historical median of 2.32. Over the past decade, Sudarshan Pharma Industries' Interest Coverage has ranged from 1.63 to 3.68. According to the industry distribution chart, Sudarshan Pharma Industries ranks #1137 out of 1277 companies in the Chemicals industry, placing it in the top 89%.
Is Sudarshan Pharma Industries' Interest Coverage too high?
Sudarshan Pharma Industries' current Interest Coverage of 1.77 is 24% below median its 10-year median of 2.32. Over the past 10 years, this metric has ranged from a low of 1.63 to a high of 3.68. The Chemicals industry median Interest Coverage is 11.53. Sudarshan Pharma Industries' value of 1.77 is 84.6% below this industry median. Based on the distribution chart, Sudarshan Pharma Industries ranks #1137 out of 1277 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Sudarshan Pharma Industries has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' Interest Coverage compare to DOW?
According to the Chemicals industry distribution chart, Sudarshan Pharma Industries ranks #1137 out of 1277 companies for Interest Coverage. This places Sudarshan Pharma Industries in the lower half of its industry. The industry median Interest Coverage is 11.53. Sudarshan Pharma Industries' value of 1.77 is 84.6% below this benchmark. Historically, Sudarshan Pharma Industries' own Interest Coverage has ranged from 1.63 to 3.68 over the past decade. While the company's 10-year median is 2.32 vs. the industry median of 11.53, Sudarshan Pharma Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Chemicals company?
The median Interest Coverage among Chemicals companies is 11.53, based on 1,277 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudarshan Pharma Industries's current Interest Coverage of 1.77 is 84.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sudarshan Pharma Industries and its competitors. For the Chemicals industry, the median Interest Coverage is 11.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudarshan Pharma Industries's current Interest Coverage is 1.77, which is 24% below median its own 10-year median of 2.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Fairly Valued. The stock's GF Value™ is ₹39.04, compared to a current price of ₹39.67 — trading 1.6% above its estimated fair value. The current Interest Coverage is 1.77, which is 24% below median its 10-year median of 2.32 and 84.6% below the Chemicals industry median of 11.53. Sudarshan Pharma Industries' overall GF Score™ is 74/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current Interest Coverage is 1.77 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?
Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued.
The current stock price of ₹39.67 is trading 1.6% above its estimated GF Value™ of ₹39.04.
GuruFocus considers Sudarshan Pharma Industries to be Fairly Valued.
Key valuation signals for BOM:543828:
Interest Coverage: 1.77 (24% below median its 10-year median of 2.32)
GF Value™: ₹39.04 vs. price of ₹39.67 (1.6% above fair value)
Industry Position: 84.6% below the Chemicals median (#1137 of 1277)
No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
74GF Score
Get the complete analysis for BOM:543828
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543828 has been successfully added to your 
